Medline to distribute Consure device
By HME News Staff
Updated 11:12 AM CDT, Wed April 3, 2024
NORTHFIELD, Ill. – Medline will exclusively distribute Consure Medical’s QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD) as part of a new agreement. Leveraging its extensive distribution network, Medline will increase the visibility of this product and enhance patient care, reduce health care costs and help clinicians better care for their patients, the company says. “Medline Urology is committed to providing essential solutions that empower clinicians to reduce the risk of CAUTIs and IADs,” said Mike Gerskovich, general manager, Medline. “QiVi MEC is Medline’s newest male external urine management device that bridges the needs of both infection prevention and WOC in their pursuit of lowering hospital-acquired infections. QiVi MEC helps clinicians provide their patients with quality urological care to achieve optimal outcomes. We are excited to add QiVi MEC to Medline’s robust urology portfolio.” QiVi MEC employs suction to divert urine output in real time. The non-absorbing pouch material keeps skin dry, as well as creates a highly precise fluid intake and outtake assessment. The catheter also provides ease of use for clinicians and keeps patient comfort in mind with its universal fit and derma-friendly, silicon-based adhesive, which creates a closed system to prevent leakage.
Comments